Abstract Details

Title Using the Selective Inhibitor of Nuclear Export (SINE) Compound KPT-350 to Reduce Cortical Circuit Hyperexcitability and Interneuron Cell Loss in the Controlled Cortical Impact (CCI) Model of Traumatic Brain Injury (TBI)

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 001

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
David Cantu, PhD (Xenon Pharmaceuticals Inc) PRESENTER	Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
	No disclosure on file
Sharon Tamir	No disclosure on file
	No disclosure on file
	No disclosure on file